Respiratory
Boehringer Ingelheim has over 90 years of heritage in respiratory disease. Since 1921 we have emerged as a leader in this disease area, having launched several treatments in a range of respiratory conditions including asthma, chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF) and lung cancer. Our focus is on improving the quality of life of patients suffering from debilitating respiratory diseases and enabling them to maintain a more independent life.
-
-
More Than Systemic Sclerosis - The Inside Story
Scleroderma
Portrait collection which showcases the unique and inspiring stories of people living with systemic sclerosis, also known as scleroderma
-
Scleroderma
A hub of knowledge, advice and support for those whose lives have been touched by scleroderma.
-
Ivan Blanarik
Respiratory
Ivan Blanarik, Therapeutic Area Head Respiratory at Boehringer Ingelheim
-
Respiratory
The US Arthritis foundation has recognised Respimat for the ease of use commendation
-
Facts on IPF
IPF
-
Lung Disease
Your online source for news and background in the field of Interstitial Lung Disease (ILD)
-
EVENT
May
19
2017
19 May 2017 09:00 AM • 24 May 2017 04:15 PM • Washington, DC • USA
-
Effective treatment discussions in IPF
IPF
In this new video watch Steve Jones and Doctor Marlies Wijsenbeek discuss the importance of treatment discussions in IPF
-
DOWNLOAD PDF (1.95 MB)
IPF Treatment DiscussionsResults of our IPF patient and physician survey around treatment discussions
-
-
Let’s meet someone living with systemic sclerosis.
Scleroderma
-
DOWNLOAD PDF (5.91 MB)
COPD EXACERBATIONS: How Simon learned to manage themHow Simon learned to manage them
-
-
-
How does it feel to live with IPF